Medical Advocates
MIV-160

Main Page

New and Noteworthy
Journal Data

ARV Investigational Drugs

Main New/Noteworthy

Home Page

Last Update: May 18, 2017
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

May 2017

In Vitro Cross-Resistance Profiles of Rilpivirine, Dapivirine and MIV-150: NNRTI Microbicides in Clinical Development for the Prevention of HIV-1 Infection.
Giacobbi NS, Sluis-Cremer N .Antimicrob Agents Chemother. 2017 May 15.

Journal Abstracts , Papers, and Commentaries

In Vitro Cross-Resistance Profiles of Rilpivirine, Dapivirine and MIV-150: NNRTI Microbicides in Clinical Development for the Prevention of HIV-1 Infection.
Giacobbi NS, Sluis-Cremer N .
Antimicrob Agents Chemother. 2017 May 15.
Abstract

ARV Investigational Drugs

Main New/Noteworthy

Home Page

MIV-160